Progress in the treatment of rheumatoid arthritis.
Publication
, Journal Article
Pisetsky, DS; St Clair, EW
Published in: JAMA
December 12, 2001
Duke Scholars
Published In
JAMA
DOI
ISSN
0098-7484
Publication Date
December 12, 2001
Volume
286
Issue
22
Start / End Page
2787 / 2790
Location
United States
Related Subject Headings
- Sulfasalazine
- Receptors, Tumor Necrosis Factor
- Penicillamine
- Minocycline
- Methotrexate
- Leflunomide
- Isoxazoles
- Infliximab
- Immunoglobulin G
- Hydroxychloroquine
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S., & St Clair, E. W. (2001). Progress in the treatment of rheumatoid arthritis. JAMA, 286(22), 2787–2790. https://doi.org/10.1001/jama.286.22.2787
Pisetsky, D. S., and E. W. St Clair. “Progress in the treatment of rheumatoid arthritis.” JAMA 286, no. 22 (December 12, 2001): 2787–90. https://doi.org/10.1001/jama.286.22.2787.
Pisetsky DS, St Clair EW. Progress in the treatment of rheumatoid arthritis. JAMA. 2001 Dec 12;286(22):2787–90.
Pisetsky, D. S., and E. W. St Clair. “Progress in the treatment of rheumatoid arthritis.” JAMA, vol. 286, no. 22, Dec. 2001, pp. 2787–90. Pubmed, doi:10.1001/jama.286.22.2787.
Pisetsky DS, St Clair EW. Progress in the treatment of rheumatoid arthritis. JAMA. 2001 Dec 12;286(22):2787–2790.
Published In
JAMA
DOI
ISSN
0098-7484
Publication Date
December 12, 2001
Volume
286
Issue
22
Start / End Page
2787 / 2790
Location
United States
Related Subject Headings
- Sulfasalazine
- Receptors, Tumor Necrosis Factor
- Penicillamine
- Minocycline
- Methotrexate
- Leflunomide
- Isoxazoles
- Infliximab
- Immunoglobulin G
- Hydroxychloroquine